Published in J Clin Invest on June 01, 1987
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev (1982) 1.81
Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci (1971) 1.35
Potential of brown adipose tissue type II thyroxine 5'-deiodinase as a local and systemic source of triiodothyronine in rats. J Clin Invest (1985) 1.34
Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats. J Clin Invest (1984) 1.15
The deiodination of the iodothyronines and of their derivatives in man. Endocr Rev (1984) 1.06
Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochem J (1979) 1.03
Metabolism of thyroid hormones and some derivatives in isolated, perfused rat liver. Am J Physiol (1965) 0.96
Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology (1985) 0.94
Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology (1985) 0.93
Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated. J Pharmacol Exp Ther (1986) 0.91
Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol (1977) 0.90
Characteristics of active transport of thyroid hormone into rat hepatocytes. Biochim Biophys Acta (1981) 0.88
Sulfation preceding deiodination of iodothyronines in rat hepatocytes. Science (1983) 0.86
Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3',5'-triiodothyronine. Endocrinology (1985) 0.85
Regulation of glucuronidation and sulfate conjugation in isolated hepatocytes. Drug Metab Dispos (1980) 0.84
Rapid deiodination of triiodothyronine sulfate by rat liver microsomal fraction. Endocrinology (1983) 0.83
Modification of rat liver iodothyronine 5'-deiodinase activity with diethylpyrocarbonate and rose bengal; evidence for an active site histidine residue. Biochem Biophys Res Commun (1984) 0.82
[The presence in the plasma of 3, 3'-diiodothyronine, a new thyroid hormone]. C R Seances Soc Biol Fil (1955) 0.82
Sulfate transfer to thyroid hormones and their analogs by hepatic aryl sulfotransferases. Endocrinology (1981) 0.80
Radioimmunoassay of 3,3'-di-iodothyronine in unextracted serum: the effect of endogenous tri-iodothyronine. J Endocrinol (1978) 0.80
On the metabolism of 3,3'-diiodothyronine and 3,3',5'-triiodothyronine. Endocrinology (1959) 0.80
Selective inhibition of sulfate conjugation in the rat: pharmacokinetics and characterization of the inhibitory effect of 2,6-dichloro-4-nitrophenol. Biochem Pharmacol (1982) 0.79
Characteristics of thyroxine 5'-deiodination in cultured human placental cells. Regulation by iodothyronines. J Clin Invest (1985) 0.79
The effect of inhibitors of mitochondrial energy production on hepatic glutathione, UDP-glucuronic acid, and adenosine 3'-phosphate-5'-phosphosulfate concentrations. Drug Metab Dispos (1986) 0.79
[Two new hormonal constituents of the thyroid gland: 3, 3'-diiodothyronine and 3, 3', 5'-triiodothyronine]. Biochim Biophys Acta (1955) 0.78
Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in man. J Clin Invest (1980) 0.78
Labeled metabolites appearing in human serum after 125I-triiodothyronine (T3) administration: a quantitative reappraisal. Metabolism (1980) 0.78
The monodeiodination of triiodothyronine and reverse triiodothyronine in man: a quantitative evaluation of the pathway by the use of turnover rate techniques. J Clin Endocrinol Metab (1984) 0.78
Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration. J Pharmacol Exp Ther (1985) 0.77
Sulfation facilitates hepatic deiodination of iodothyronines. Horm Metab Res Suppl (1984) 0.77
Metabolism of 3,3'-diiodothyronine in rat hepatocytes: interaction of sulfation with deiodination. Endocrinology (1984) 0.77
Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation. Biochem Pharmacol (1982) 0.77
Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes. J Pharm Sci (1981) 0.77
THE EFFECT OF HINDERED PHENOLS ON MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION. J Biol Chem (1965) 0.76
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology (2000) 2.50
Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health (1998) 2.24
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J (1976) 1.57
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
[Cardiovascular effects of hyperthyroidism and their treatment]. Ned Tijdschr Geneeskd (2002) 1.39
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver. J Nucl Med (1993) 1.38
Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc Natl Acad Sci U S A (1982) 1.37
Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol (1993) 1.34
Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J Clin Invest (1983) 1.30
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med (2001) 1.30
Cerebral cortex responds rapidly to thyroid hormones. Science (1981) 1.29
In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol (1998) 1.22
Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab (2001) 1.20
Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology (1996) 1.20
Sequential deiodination of thyroxine in rat liver homogenate. Biochem J (1978) 1.18
Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci Res (1995) 1.16
Inhibition of thyroid hormone sulfation by hydroxylated metabolites of polychlorinated biphenyls. Chem Biol Interact (1998) 1.15
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology (2001) 1.12
Thyroid hormone transporters. Biochem Soc Trans (2005) 1.10
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab (1998) 1.08
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
Mechanism of action of iodothyronine-5'-deiodinase. Biochim Biophys Acta (1979) 1.08
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med (2001) 1.07
Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab (2008) 1.06
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology (2005) 1.05
Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol (Oxf) (1981) 1.05
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med (1997) 1.04
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur J Nucl Med (1999) 1.04
A tentative review of recent in vitro observations of the enzymatic deiodination of iodothyronines and its possible physiological implications. Mol Cell Endocrinol (1978) 1.04
Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochem J (1979) 1.03
Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology (1999) 1.02
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology (1991) 1.01
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Identification of thyroid hormone transporters. Biochem Biophys Res Commun (1999) 1.00
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol (1992) 0.99
Regulation of thyroid hormone metabolism during fetal development. Mol Cell Endocrinol (1999) 0.98
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med (1997) 0.97
Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. Endocrinology (1984) 0.97
Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochim Biophys Acta (1979) 0.97
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol (2006) 0.96
Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett (1994) 0.96
Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. J Clin Endocrinol Metab (2001) 0.95
Different pathways of iodothyronine 5'-deiodination in rat cerebral cortex. Biochem Biophys Res Commun (1981) 0.95
Interlaboratory variation of vitamin D1) metabolite measurements. J Clin Chem Clin Biochem (1982) 0.94
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology (1994) 0.94
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology (1985) 0.94
Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology (1993) 0.94
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history. Ann N Y Acad Sci (1994) 0.94
Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology (1985) 0.93
Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci (1984) 0.93
Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) (2008) 0.92
Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab (2000) 0.92
Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology (2003) 0.92
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid (2004) 0.91
Substrate requirement for inactivation of iodothyronine-5'-deiodinase activity by thiouracil. Biochim Biophys Acta (1981) 0.91
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2011) 0.91
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (1998) 0.91
Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol (1977) 0.90
Photophysics of the single tryptophan residue in Fusarium solani Cutinase: evidence for the occurrence of conformational substates with unusual fluorescence behaviour. Biophys Chem (1996) 0.90
In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: isozyme specificity and inhibition kinetics. Toxicol Sci (1998) 0.90
Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab (1996) 0.90
Hypothalamo-hypophysial-thyroid axis in streptozotocin-induced diabetes. Endocrinology (1992) 0.89
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med (1996) 0.89
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (2000) 0.88
Rat liver type I iodothyronine deiodinase is not identical to protein disulfide isomerase. Biochem Biophys Res Commun (1989) 0.88
Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. Eur J Endocrinol (2009) 0.88
Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab (1999) 0.87
One enzyme for the 5'-deiodination of 3,3',5'-triiodothyronine and 3',5'-diiodothyronine in rat liver. Biochem Pharmacol (1982) 0.87
Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J (Clin Res Ed) (1981) 0.87
Radiolabelled regulatory peptides for imaging and therapy. Anticancer Agents Med Chem (2007) 0.86
Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed (2003) 0.86
Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase. Endocrinology (1997) 0.86
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy. Int J Cancer (1999) 0.86
Sulfation preceding deiodination of iodothyronines in rat hepatocytes. Science (1983) 0.86
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours. Clin Endocrinol (Oxf) (2002) 0.86
Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem Pharmacol (1993) 0.86
Serum thyrotrophin concentration: an unreliable test for detection of early hypothyroidism after thyroidectomy. Br Med J (1975) 0.86
Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf) (2007) 0.86
Solubilization and partial characterization of rat liver iodothyronine deiodinases. Biochim Biophys Acta (1980) 0.85
Uptake of triiodothyronine and triiodothyroacetic acid in neonatal rat cardiomyocytes: effects of metabolites and analogs. J Endocrinol (2002) 0.85
Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives. Clin Endocrinol (Oxf) (1981) 0.85
Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab (1999) 0.85
Determinants of polychlorinated biphenyls (PCBs) in human milk. Acta Paediatr Scand (1988) 0.85
Inhibition of iodothyronine 5'-deiodinase by thioureylenes; structure--activity relationship. FEBS Lett (1979) 0.85
Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism. Clin Endocrinol (Oxf) (1982) 0.85
Regulation of hypothalamic TRH production and release in the rat. Acta Med Austriaca (1992) 0.85
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int J Cancer (1999) 0.85
Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. J Med Genet (2005) 0.85
Hypothyroidism induces type I iodothyronine deiodinase expression in tilapia liver. Gen Comp Endocrinol (2001) 0.84
Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans. J Clin Endocrinol Metab (1997) 0.84
Congenital hypothyroidism and partial thyroid hormone unresponsiveness of the pituitary in a patient with congenital thyroxine binding albumin elevation. Eur J Pediatr (1989) 0.84